FDA issues update on mortality risk with paclitaxel-coated products
(HealthDay)—A preliminary analysis has revealed a "potentially concerning signal" of increased long-term mortality risk with paclitaxel-coated products indicated for peripheral arterial disease (PAD), according to a March ...
Mar 19, 2019
0
1